Xilio Therapeutics, Inc.
XLO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001840233
No open-market purchases or sales by Xilio Therapeutics, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $32.6M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Xilio Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- −4 vs. Q2 2022
- Shares held
- 16.6M
- −1.27M (−7.1%) vs. Q2 2022
- Total value
- $48.3M
- −$3.89M (−7.4%) vs. Q2 2022
- New holders
- 3
- 3 more added
- Sold out
- 7
- 9 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting XLO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $32.6M |
| Q1 2026 | 24 | $22.0M |
| Q4 2025 | 37 | $25.4M |
| Q3 2025 | 36 | $18.6M |
| Q2 2025 | 35 | $16.2M |
| Q1 2025 | 35 | $16.3M |
| Q4 2024 | 35 | $24.7M |
| Q3 2024 | 33 | $12.6M |
| Q2 2024 | 32 | $13.7M |
| Q1 2024 | 31 | $13.5M |
| Q4 2023 | 34 | $9.03M |
| Q3 2023 | 31 | $33.5M |
| Q2 2023 | 32 | $41.9M |
| Q1 2023 | 32 | $51.0M |
| Q4 2022 | 28 | $42.8M |
| Q3 2022 | 29 | $48.3M |
| Q2 2022 | 33 | $52.2M |
| Q1 2022 | 41 | $132.7M |
| Q4 2021 | 42 | $303.1M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Xilio Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,805,413 | $8.16M | 0.97% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 2,759,344 | $8.03M | 0.89% | 00.0% | Unchanged |
| Octagon Capital Advisors LP | 2,425,000 | $7.06M | 1.22% | +2,425,000 | New |
| FMR LLC | 2,219,762 | $6.46M | 0.00% | −301,571−12.0% | Reduced |
| RiverVest Venture Management LLC | 1,441,444 | $4.20M | 4.87% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 1,362,878 | $3.97M | 0.10% | 00.0% | Unchanged |
| Vanguard Group Inc | 891,533 | $2.60M | 0.00% | +472,368+112.7% | Added |
| AJU IB Investment Co., Ltd. | 667,742 | $1.94M | 3.33% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 453,660 | $1.32M | 0.18% | 00.0% | Unchanged |
| Artal Group S.A. | 450,000 | $1.31M | 0.07% | 00.0% | Unchanged |
| Harvard Management Co Inc | 416,059 | $1.21M | 0.15% | 00.0% | Unchanged |
| FIL Ltd | 218,705 | $636.0K | 0.00% | 00.0% | Unchanged |
| Laurion Capital Management LP | 142,900 | $416.0K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 83,589 | $243.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 76,081 | $221.0K | 0.01% | +76,081 | New |
| BlackRock Inc. | 46,358 | $135.0K | 0.00% | −1,305−2.7% | Reduced |
| Renaissance Technologies LLC | 28,500 | $83.0K | 0.00% | −46,800−62.2% | Reduced |
| Millennium Management LLC | 27,631 | $80.0K | 0.00% | −22,325−44.7% | Reduced |
| Cannell Capital LLC | 17,025 | $50.0K | 0.01% | +12,480+274.6% | Added |
| State Street Corp | 15,690 | $46.0K | 0.00% | 00.0% | Unchanged |
| Ergoteles LLC | 12,941 | $38.0K | 0.00% | −4,607−26.3% | Reduced |
| Northern Trust Corp | 12,900 | $38.0K | 0.00% | 00.0% | Unchanged |
| RBF Capital, LLC | 10,072 | $29.0K | 0.00% | 00.0% | Unchanged |
| Nwam LLC | 10,000 | $29.0K | 0.00% | +10,000 | New |
| Morgan Stanley | 6,840 | $20.0K | 0.00% | −200−2.8% | Reduced |
| JPMorgan Chase & Co | 2,704 | $8.00K | 0.00% | −31−1.1% | Reduced |
| Tower Research Capital LLC (TRC) | 2,069 | $6.00K | 0.00% | −4,086−66.4% | Reduced |
| UBS Group AG | 201 | $1.00K | 0.00% | −2,613−92.9% | Reduced |
| Wells Fargo & Company | 75 | $0 | 0.00% | +24+47.1% | Added |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −2,078,692−100.0% | Sold out |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −1,649,711−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −121,887−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −36,632−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −64−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −67−100.0% | Sold out |